Titlebook: Liver Cancer in the Middle East; Brian I. Carr Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Sprin

Intellectual

Transarterial Radioembolization in Hepatocellular Carcinoma HCC patients, liver transplantation (LT) is the best choice because it reduces new HCC lesions due to the treatment of liver cirrhosis. But every patient is not a candidate for LT because of suitability of the patient (tumor size, macrovascular invasion, etc.) and availability of organ. For these u

玉米

Intra-arterial Chemotherapy and Transarterial Chemoembolization in Hepatocellular Carcinomacancer-related mortality. Patient stratification and treatment allocation are based on tumour stage, liver function, and performance status. About 80% of patients with HCC are diagnosed with disease that is not amenable to liver transplantation or surgical resection. A majority of patients with unre

自愛

Radiotherapy for Hepatocellular Carcinomarged as a safe, noninvasive, and effective treatment for patients with unresectable tumors with a local control reaching 96% at 3?years. SBRT delivers highly conformal radiation therapy while sparing the intact liver, with a high local control and minimal side effects. This chapter focuses on the ro